New: Introducing the Finviz Crypto Map

Learn More

CME Q2 Earnings, Revenues Beat Estimates on Higher Trading Volume

By Zacks Equity Research | July 23, 2025, 12:06 PM

CME Group CME reported second-quarter 2025 operating income of $2.96 per share, which beat the Zacks Consensus Estimate by 1.7%. The bottom line improved 15.6% year over year. 

Quarterly results benefited from improving revenues, driven by higher clearing and transaction fees as well as market data and information services fees.  Increased volatility drove volumes.

Performance in Detail

CME Group’s revenues of $1.7 billion increased 10.4% year over year. The year-over-year increase was primarily due to higher clearing and transaction fees (up 11% year over year) and market data and information services (up 13.2% year over year). The top line beat the Zacks Consensus Estimate by 0.5%.

CME Group Inc. Price, Consensus and EPS Surprise

CME Group Inc. Price, Consensus and EPS Surprise

CME Group Inc. price-consensus-eps-surprise-chart | CME Group Inc. Quote

Total expenses rose 5.8% year over year to $562.7 million, attributable to higher compensation and benefits, technology, professional fees and outside services and licensing and other fee agreements. It exceeded our estimate of $513.7 million.

Operating income increased 12.9% from the prior-year quarter to $1.1 billion. Our estimate was $1.1 billion.

Given heightened economic uncertainty, average daily volume (“ADV”) was a record 30.2 million contracts, up 16% year over year. ADV increased across all product lines. The total average rate per contract was 69 cents.

Financial Update

As of June 30, 2025, CME Group had $1.5 billion of cash and marketable securities, down 30.1% from the 2024-end level. 

As of June 30, 2025, long-term debt was $3.4 billion, up 27.7% from 2024-end. 

As of June 30, 2025, CME had shareholders' equity worth $27.7 billion, up 4.7% from the end of 2024.

Capital Deployment

CME Group declared dividends of $3 billion in the first half of 2025. It has returned over $29.1 billion to shareholders in the form of dividends since the implementation of its variable dividend policy in early 2012.

Zacks Rank

CME currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Upcoming Releases

Nasdaq NDAQ will report second-quarter 2025 results on July 24, before market open. The Zacks Consensus Estimate for second-quarter earnings per share is pegged at 80 cents, suggesting an increase of 15.9% from the year-ago quarter’s reported figure.

NDAQ’s earnings beat estimates in each of the last four quarters.

Intercontinental Exchange ICE will report second-quarter 2025 results on July 31, before market open. The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $1.76, suggesting an increase of 17.8% from the year-ago quarter’s reported figure.

ICE’s earnings beat estimates in each of the last four quarters.

Cboe Global Markets CBOE will report second-quarter 2025 results on Aug. 1 before market open. The Zacks Consensus Estimate for second-quarter earnings per share is pegged at $2.43, suggesting an increase of 13% from the year-ago quarter’s reported figure.

CBOE’s earnings beat estimates in three of the last four quarters and missed in one.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Intercontinental Exchange Inc. (ICE): Free Stock Analysis Report
 
CME Group Inc. (CME): Free Stock Analysis Report
 
Nasdaq, Inc. (NDAQ): Free Stock Analysis Report
 
Cboe Global Markets, Inc. (CBOE): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Latest News